Novo Nordisk A/S ADR (NVO)

$132.28 0.73 (0.56%)

10:01 EDT NVO Stock Quote Delayed 30 Minutes

The New Magnificent 7: 7 Stocks Rising to Prominence

By Alex Sirois, InvestorPlace Contributor Dec 15, 2023

The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

7 Stocks Set to Capitalize on the Coming Year-End Rally

3 Consumer Goods Stocks That Will Define the Next Decade

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 475,144

Day's Range $131.89 - $133.18

52-Week Range $77.96 - $148.15

Dividend & Yield $1.77 (1.34%)

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

7 A-Rated Retirement Stocks for Your November Buy List

By Louis Navellier and the InvestorPlace Research Staff Nov 17, 2023

I know very few people who don’t look forward to retirement. Retirement means your life’s labor is done and you’ve achieved your financial goals. Whether…

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

By Alex Sirois, InvestorPlace Contributor Nov 13, 2023

Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

7 Biotech Stocks to Buy for Big-Time Gains

By Louis Navellier and the InvestorPlace Research Staff Nov 10, 2023

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

7 A-Rated Tech Stocks to Buy for November

By Louis Navellier and the InvestorPlace Research Staff Nov 2, 2023

By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.

3 Monster Buy-and-Hold Growth Stocks to Buy Right Now for $1K

By Rich Duprey, InvestorPlace Contributor Oct 27, 2023

These are three growth stocks you will want to buy and never sell if you have $1,000 available to invest today.

3 Healthcare Stocks to Invest in for a Big Shot of Gains

By Joel Baglole, InvestorPlace Contributor Oct 23, 2023

Most healthcare stocks are down across the board. Pharma companies, health insurers, and medical device manufacturers have all seen their share prices decline. That said, there are a few stocks that have managed to separate themselves from the pack with new innovations and strong financial results.

7 Stocks to Buy and Hold for a Lifetime of Wealth

By Louis Navellier and the InvestorPlace Research Staff Oct 19, 2023

The best way to live a stress-free life and build wealth in the long term is to choose stocks to buy and hold. Here are seven that fit the bill.

7 Affordable Stocks to Invest in as America’s Population Ages

By Alex Sirois, InvestorPlace Contributor Oct 12, 2023

Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors.

Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns

By John Blankenhorn, InvestorPlace Contributor Oct 2, 2023

These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor Sep 28, 2023

The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020.

3 Phenomenal Stock-Split Stocks You Should Be Buying Now

By Rich Duprey, InvestorPlace Contributor Sep 18, 2023

These three fantastic stock-split stocks are stocks investors should be buying in the wake of last year's wave of splits.

Is This a Dead-Cat Bounce? 3 Must-Buy Stocks Just in Case.

By Rich Duprey, InvestorPlace Contributor Sep 13, 2023

History suggests the market is ready to run higher, but it could also be a false positive that results in a dead-cat bounce.

Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?

By Samuel O'Brient, InvestorPlace Reporter Sep 13, 2023

Ozempic producer Novo Nordisk is about to split its stock again. Here's why investors should be watching NVO stock closely.

Why Is Novo Nordisk (NVO) Stock Up 95% Today?

By William White, InvestorPlace Writer Sep 13, 2023

Novo Nordisk (NVO) stock is on the rise Wednesday after the pharmaceutical company announced an upcoming split of its shares.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 13, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!

Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold

By Joel Baglole, InvestorPlace Contributor Sep 11, 2023

Excitement is building around the potential health and financial benefits of these new weight-loss medications.

The 3 Best Stocks to Buy Now: September 2023

By Michael Que, InvestorPlace Contributor Sep 7, 2023

With the United States economy demonstrating strong performance recently, Federal Reserve officials are considering to double their 2023 growth projections. Economic data has consistently exceeded…

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Sep 7, 2023

These Nasdaq stocks to sell are all risky plays with uncertain futures. It's a good idea to sell or trim your positions in them now.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

By Louis Navellier and the InvestorPlace Research Staff Sep 7, 2023

Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

Novo Nordisk Stock Outlook: Popular Prescriptions Seal the Deal

By Louis Navellier and the InvestorPlace Research Staff Aug 10, 2023

NVO stock took a breather after a huge rally, but it's probably headed higher as Novo Nordisk commercializes its famous weight-loss drug.

Novo Nordisk A/S ADR (NVO)

The New Magnificent 7: 7 Stocks Rising to Prominence

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

7 Stocks Set to Capitalize on the Coming Year-End Rally

3 Consumer Goods Stocks That Will Define the Next Decade

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novo Nordisk A/S ADR (NVO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

Subscriber Sign in